Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 3-year international, observational cohort study of treatment outcomes in adult patients with moderate-to-severe plaque psoriasis

Next Previous
X
Search
Trial Profile

A 3-year international, observational cohort study of treatment outcomes in adult patients with moderate-to-severe plaque psoriasis

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 May 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ixekizumab (Primary) ; Secukinumab (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms PSoHO

    • Most Recent Events

    • 21 Mar 2023 Results of post-hoc analysis (n=1772) assessing the percentage of bio-naive and bio-experienced patients with greater than equal to PASI90 and/or sPGA(0/1) at week 12 who received FDA-approved dosing by treatment cohort (IL-17A cohort [ixekizumab and secukinumab] and other biologics cohort [biosimilars, with greater than equal to 50 pts; ustekinumab, brodalumab, adalimumab, guselkumab, risankizumab, tildrakizumab), presented at the American Academy of Dermatology annual Meeting 2023.
    • 14 Dec 2022 Week 12 results (n=1981) assessing the effectiveness of anti-IL-17A biologics versus other biologics across seven clinically relevant subgroups, published in the Advances in Therapy
    • 01 Nov 2022 Results assessing comparative effectiveness in clinical practice at week 24 published in the Journal of the European Academy of Dermatology and Venereology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top